Baroness Hilary Cass, who wrote Cass Review into children's gender care, said there is no evidence puberty blockers help with ...

First-in-human results for three investigational inhibitors show anti-tumor activity without unmanageable effects on blood glucose.

A new study, published in the New England Journal of Medicine, examines whether removing lymph nodes is always necessary in ...

The Biden administration has called for Medicare and Medicaid to expand coverage of weight-loss drugs for people struggling ...

B reast cancer is not a single disease but multiple ones, each carrying varying degrees of risk for endangering women’s ...

Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who underwent active monitoring had similar two-year invasive ipsilateral breast ...

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

Find out which natural cures work and which don't, including supplements for a healthier heart, chiropractic to ease back ...

While other big pharmas have faltered, Lilly made headway in a Phase 3 trial that could provide a treatment option to replace ...

Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free survival in patients with endocrine therapy-pretreated, ER-positive, ...

Gameday Men's Health, a business which offers concierge testosterone replacement therapy and related services, opened a ...

Novo Nordisk's Lotte Bjerre Knudsen says her determination is a key part of the success, but she also stays humble.